Sotac Pharmaceuticals (NSE:SOTAC) Ending Cash Position : ₹0 Mil (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Sotac Pharmaceuticals Ending Cash Position?

Sotac Pharmaceuticals's Ending Cash Position for the quarter that ended in Sep. 2024 was ₹0 Mil.

Sotac Pharmaceuticals's annual Ending Cash Position increased from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹97 Mil) but then declined from Mar. 2023 (₹97 Mil) to Mar. 2024 (₹34 Mil).

Sotac Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Sotac Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sotac Pharmaceuticals Ending Cash Position Chart

Sotac Pharmaceuticals Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Ending Cash Position

4.28

2.69

0.28

96.82

34.18

Sotac Pharmaceuticals Quarterly Data
	Mar20	Mar21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial								-	-	-	-	-

Sotac Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sotac Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	96.815	+	-62.637
	=	34

Sotac Pharmaceuticals's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0

Sotac Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Sotac Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Sotac Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sotac Pharmaceuticals Ltd (NSE:SOTAC) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

Plot No. PF-21, Near ACME Pharma, Opposite Teva Pharma Sanand GIDC-II, Sanand, Ahmedabad, GJ, IND, 382110

Website

https://www.sotacpharma.com

Sotac Pharmaceuticals Ltd is a pharma manufacturer, specializing in the manufacturing of a wide range of pharmaceutical products such as Non-Beta-Lactam (general) tablets, beta-lactam coated tablets, beta-lactam uncoated tablets, Non-Beta-Lactam (general) capsules, beta-lactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray, and cream.

Sotac Pharmaceuticals Headlines

No Headlines